Cipher Pharmaceuticals Inc (TSE:CPH) has released an update.
Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Cipher Pharmaceuticals Inc. reported a modest year-over-year revenue growth of 2.4% to $21.2 million for 2023, alongside an increase in adjusted EBITDA by 2.2%. Their cash position stood at $39.8 million at the end of the year, with a notable 10% growth in Epuris revenue during the fourth quarter. The company also repurchased and cancelled over 1.5 million common shares under its issuer bid programs, reflecting its ongoing capital management strategies.
For further insights into TSE:CPH stock, check out TipRanks’ Stock Analysis page.
